X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8578) 8578
Book Review (1200) 1200
Publication (404) 404
Magazine Article (114) 114
Newsletter (53) 53
Conference Proceeding (36) 36
Book Chapter (10) 10
Book / eBook (6) 6
Newspaper Article (3) 3
Government Document (2) 2
Reference (2) 2
Data Set (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7774) 7774
index medicus (7197) 7197
zidovudine - therapeutic use (4985) 4985
aids/hiv (4779) 4779
hiv infections - drug therapy (4046) 4046
female (3737) 3737
zidovudine (3550) 3550
anti-hiv agents - therapeutic use (3093) 3093
male (3089) 3089
adult (2893) 2893
infectious diseases (2072) 2072
hiv (2067) 2067
aids (1738) 1738
drug therapy, combination (1670) 1670
acquired immunodeficiency syndrome - drug therapy (1532) 1532
pregnancy (1470) 1470
abridged index medicus (1407) 1407
immunology (1404) 1404
middle aged (1263) 1263
hiv infections - transmission (1144) 1144
human-immunodeficiency-virus (1119) 1119
pharmacology & pharmacy (1109) 1109
reverse transcriptase inhibitors - therapeutic use (1103) 1103
cd4 lymphocyte count (1086) 1086
virology (1063) 1063
hiv infections - virology (1049) 1049
viral load (1027) 1027
drug therapy (1022) 1022
hiv-1 - drug effects (1009) 1009
zidovudine - administration & dosage (976) 976
hiv infections - prevention & control (968) 968
lamivudine - therapeutic use (946) 946
hiv-1 (942) 942
antiretroviral therapy (935) 935
infant, newborn (934) 934
infectious disease transmission, vertical - prevention & control (921) 921
hiv infection (908) 908
medicine, general & internal (874) 874
hiv-1 - genetics (835) 835
zidovudine - adverse effects (835) 835
antiviral agents - therapeutic use (818) 818
infection (770) 770
human immunodeficiency virus (740) 740
therapy (739) 739
hiv infections - immunology (730) 730
lamivudine (720) 720
pregnancy complications, infectious - drug therapy (692) 692
treatment outcome (683) 683
zidovudine - pharmacology (683) 683
infant (680) 680
animals (665) 665
didanosine - therapeutic use (663) 663
human immunodeficiency virus--hiv (623) 623
time factors (621) 621
health aspects (590) 590
child (589) 589
adolescent (583) 583
risk factors (572) 572
hiv protease inhibitors - therapeutic use (570) 570
anti-hiv agents - administration & dosage (566) 566
antiviral agents (557) 557
hiv infections - complications (543) 543
anti-hiv agents - adverse effects (534) 534
rna, viral - blood (531) 531
antiretroviral drugs (524) 524
research (514) 514
microbiology (499) 499
mutation (490) 490
prevention (470) 470
antiretroviral therapy, highly active (467) 467
cohort studies (464) 464
nevirapine - therapeutic use (459) 459
clinical trials as topic (457) 457
anti-hiv agents - pharmacology (454) 454
prospective studies (452) 452
acquired immunodeficiency syndrome - complications (431) 431
highly active antiretroviral therapy (430) 430
immunodeficiency-virus type-1 (430) 430
hiv infections - epidemiology (428) 428
hiv-1 - isolation & purification (427) 427
nevirapine (426) 426
retrospective studies (426) 426
child, preschool (423) 423
follow-up studies (423) 423
azt (404) 404
protease inhibitors (404) 404
infections (369) 369
viruses (366) 366
disease progression (365) 365
zalcitabine - therapeutic use (360) 360
pharmacokinetics (359) 359
stavudine - therapeutic use (353) 353
hiv infections - blood (352) 352
united states (351) 351
aids-related complex (346) 346
double-blind (346) 346
placebo-controlled trial (343) 343
drug resistance (330) 330
type-1 (327) 327
acquired immune deficiency syndrome (325) 325
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
May be requested (1) 1
New College (Ivey) - Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
UTL at Downsview - May be requested (1) 1
UTL at Downsview - Pharmacy (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8205) 8205
French (167) 167
Spanish (140) 140
German (102) 102
Italian (30) 30
Dutch (25) 25
Japanese (21) 21
Portuguese (15) 15
Chinese (13) 13
Russian (13) 13
Polish (10) 10
Danish (8) 8
Norwegian (5) 5
Serbian (3) 3
Swedish (3) 3
Finnish (2) 2
Hebrew (2) 2
Hungarian (2) 2
Czech (1) 1
Korean (1) 1
Lithuanian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 7, pp. 775 - 784
Summary Background Problems associated with lifelong antiretroviral therapy, such as need for strict adherence, drug-related toxic effects, difficulties with... 
Infectious Disease | INFECTIOUS DISEASES | ABACAVIR-LAMIVUDINE | EFFICACY | SAFETY | NAIVE HIV-1-INFECTED PATIENTS | ACTIVE ANTIRETROVIRAL THERAPY | ONCE-DAILY ATAZANAVIR/RITONAVIR | TWICE-DAILY LOPINAVIR/RITONAVIR | INFECTED PATIENTS | PROTEASE INHIBITORS | TENOFOVIR | HIV-1 | Humans | Middle Aged | Male | RNA, Viral - blood | Viral Load | Oligopeptides - therapeutic use | Reverse Transcriptase Inhibitors - adverse effects | Tenofovir | Deoxycytidine - therapeutic use | Drug Therapy, Combination - adverse effects | Adenine - therapeutic use | Lamivudine - therapeutic use | Atazanavir Sulfate | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Pyridines - therapeutic use | Emtricitabine | HIV Protease Inhibitors - adverse effects | Adenine - analogs & derivatives | Organophosphonates - therapeutic use | Anti-HIV Agents - adverse effects | HIV Infections - virology | HIV Protease Inhibitors - therapeutic use | Drug Therapy, Combination - methods | HIV Infections - drug therapy | Zidovudine - therapeutic use | Drug Substitution | Deoxycytidine - analogs & derivatives | Studies | Antiretroviral drugs | Heart attacks | Protease inhibitors | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Clinical trials | Infections | Mutation | Drug therapy | Failure | Cost control | Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9787, pp. 229 - 237
Summary Background The non-nucleoside reverse transcriptase inhibitor (NNRTI), rilpivirine (TMC278; Tibotec Pharmaceuticals, County Cork, Ireland), had... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | ZIDOVUDINE | COMBINATION THERAPY | ACTIVE ANTIRETROVIRAL THERAPY | EMTRICITABINE | PROTEASE-INHIBITOR | CYSTATIN-C | CREATININE | DAILY LAMIVUDINE | NEVIRAPINE | TENOFOVIR | Rilpivirine | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Middle Aged | Male | Anti-HIV Agents - administration & dosage | Nitriles - administration & dosage | Tenofovir | Deoxycytidine - therapeutic use | Nucleotides - therapeutic use | Adenine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Acquired Immunodeficiency Syndrome - virology | Acquired Immunodeficiency Syndrome - ethnology | Emtricitabine | Nucleosides - therapeutic use | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Organophosphonates - therapeutic use | HIV-1 - drug effects | Pyrimidines - administration & dosage | Anti-HIV Agents - adverse effects | Benzoxazines - adverse effects | Treatment Outcome | HIV-1 - genetics | Acquired Immunodeficiency Syndrome - drug therapy | Benzoxazines - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Mutation | Nitriles - adverse effects | Viral Load - drug effects | Deoxycytidine - analogs & derivatives | Nitriles - therapeutic use | Evaluation | Patient outcomes | Clinical trials | Dosage and administration | Drug therapy | HIV infection | Design | Antiretroviral drugs | Corporate sponsorship | Human immunodeficiency virus--HIV | Technological change | Research | Clinical medicine | Drugs | RNA-directed DNA polymerase | Exanthema | antiretroviral therapy | Lamivudine | Lipids | Nucleotides | Regression analysis | Efavirenz | CD4 antigen | nucleosides | Algorithms | Hospitals | non-nucleoside reverse transcriptase inhibitors | Abacavir | Zidovudine | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 10/2008, Volume 198, Issue 8, pp. 1113 - 1122
Background. Vicriviroc (VCV) is a CCR5 antagonist with nanomolar activity against human immunodeficiency virus (HIV) replication in vitro and in vivo. We... 
HIV/AIDS | Tropisms | RNA | HIV | Placebos | Viruses | AIDS | Infections | Dosage | HIV 1 | Virology | INFECTIOUS DISEASES | MYOCARDIAL-INFARCTION | MICROBIOLOGY | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | PROGNOSTIC VALUE | CCR5 ANTAGONIST | INDIVIDUALS | ANTIRETROVIRAL-DRUG-RESISTANCE | SYNCYTIUM-INDUCING PHENOTYPE | EPIDEMIOLOGY | DISEASE PROGRESSION | Piperazines - administration & dosage | Lamivudine - administration & dosage | Humans | Male | RNA, Viral - blood | Reverse Transcriptase Inhibitors - administration & dosage | Viral Load | Zidovudine - administration & dosage | Anti-HIV Agents - administration & dosage | Lamivudine - adverse effects | Reverse Transcriptase Inhibitors - adverse effects | HIV-1 - physiology | Lamivudine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Drug Therapy, Combination | CCR5 Receptor Antagonists | Benzoxazines - administration & dosage | Double-Blind Method | Zidovudine - adverse effects | HIV-1 - drug effects | Pyrimidines - administration & dosage | Anti-HIV Agents - adverse effects | HIV Infections - virology | Benzoxazines - adverse effects | Treatment Outcome | CD4 Lymphocyte Count | Piperazines - therapeutic use | Piperazines - adverse effects | Benzoxazines - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | HIV Infections - drug therapy | Zidovudine - therapeutic use | Lamivudine | Dosage and administration | HIV (Viruses) | Drug therapy | Zidovudine | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2006, Volume 354, Issue 3, pp. 251 - 260
Journal Article
by Mugyenyi, P and Walker, AS and Hakim, J and Munderi, P and Gibb, DM and Kityo, C and Reid, A and Grosskurth, H and Darbyshire, JH and Ssali, F and Bray, D and Katabira, E and Babiker, AG and Gilks, CF and Kabuye, G and Nsibambi, D and Kasirye, R and Zalwango, E and Nakazibwe, M and Kikaire, B and Nassuna, G and Massa, R and Fadhiru, K and Namyalo, M and Zalwango, A and Generous, L and Khauka, P and Rutikarayo, N and Nakahima, W and Mugisha, A and Todd, J and Levin, J and Muyingo, S and Ruberantwari, A and Kaleebu, P and Yirrell, D and Ndembi, N and Lvagoba, F and Hughes, P and Aber, M and Lara, AM and Foster, S and Amurwon, J and Wakholi, BN and Whitworth, J and Wangati, K and Amuron, B and Kajungu, D and Nakiyingi, J and Omony, W and Tumukunde, D and Otim, T and Kabanda, J and Musana, H and Akao, J and Kyomugisha, H and Byamukama, A and Sabiiti, J and Komugyena, J and Wavamunno, P and Mukiibi, S and Drasiku, A and Byaruhanga, R and Labeja, O and Katundu, P and Tugume, S and Awio, P and Namazzi, A and Bakeinyaga, GT and Katabira, H and Abaine, D and Tukamushaba, J and Anywar, W and Ojiambo, W and Angweng, E and Murungi, S and Haguma, W and Atwiine, S and Kigozi, J and Namale, L and Mukose, A and Mulindwa, G and Atwiine, D and Muhwezi, A and Nimwesiga, E and Barungi, G and Takubwa, J and Mwebesa, D and Kagina, G and Mulindwa, M and Ahimbisibwe, F and Mwesigwa, P and Akuma, S and Zawedde, C and Nyiraguhirwa, D and Tumusiime, C and Bagaya, L and Namara, W and Karungi, J and Kankunda, R and ... and DART Trail Grp and DART Trial Team
Lancet, The, ISSN 0140-6736, 2010, Volume 375, Issue 9709, pp. 123 - 131
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 05/2012, Volume 56, Issue 5, pp. 2305 - 2313
OA  Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley... 
ABACAVIR | LAMIVUDINE | SUBSTITUTION | DIDANOSINE | ZIDOVUDINE | IMMUNODEFICIENCY-VIRUS TYPE-1 | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | HIV-1-INFECTED PATIENTS | ANTIRETROVIRAL THERAPY | DRUG-RESISTANCE | TENOFOVIR | Genomics | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | HIV Reverse Transcriptase - genetics | Reverse Transcriptase Inhibitors - administration & dosage | Thymidine - therapeutic use | Zidovudine - administration & dosage | Anti-HIV Agents - administration & dosage | Tenofovir | Thymidine - administration & dosage | Adenine - therapeutic use | HIV-1 - isolation & purification | Anti-HIV Agents - therapeutic use | Dideoxynucleosides - therapeutic use | Nucleosides - genetics | Reverse Transcriptase Inhibitors - therapeutic use | Dideoxynucleosides - administration & dosage | Drug Resistance, Multiple, Viral - drug effects | Adenine - analogs & derivatives | Drug Resistance, Multiple, Viral - genetics | Organophosphonates - therapeutic use | HIV-1 - drug effects | HIV Infections - virology | Genotype | HIV-1 - genetics | Adenine - administration & dosage | Organophosphonates - administration & dosage | Phenotype | Algorithms | Least-Squares Analysis | HIV Infections - drug therapy | Zidovudine - therapeutic use | Mutation | Index Medicus | nucleosides | RNA-directed DNA polymerase | tenofovir | Abacavir | Data processing | Thymidine | Drug resistance | Statistics | Antiviral Agents
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2012, Volume 366, Issue 25, pp. 2380 - 2389
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 01/2008, Volume 47, Issue 1, pp. 74 - 78
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2009, Volume 361, Issue 23, pp. 2230 - 2240
Journal Article
Tropical Medicine & International Health, ISSN 1360-2276, 07/2015, Volume 20, Issue 7, pp. 914 - 918
OBJECTIVE To compare virologic success between adult patients on tenofovir (TDF) and zidovudine (AZT)-containing first-line antiretroviral (ART) regimens in 10... 
Terapia Antirretroviral | zidovudine | tenofovir | nucleoside reverse transcriptase inhibitor | Africa | anti‐retroviral therapy | thérapie antirétrovirale | Inhibidor Nucleósido de la Transcriptasa Inversa | l'Afrique | África | viral load | HIV | VIH | charge virale | inhibiteur de la transcriptase inverse nucléosidique | Zidovudina | ténofovir | Carga Viral | Tenofovir | Anti-retroviral therapy | Nucleoside reverse transcriptase inhibitor | Viral load | Zidovudine | LESOTHO HEALTH CENTERS | ZIDOVUDINE/LAMIVUDINE | EMTRICITABINE | ANTIRETROVIRAL THERAPY | TROPICAL MEDICINE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | NAIVE PATIENTS | DISOPROXIL FUMARATE | EFAVIRENZ | anti-retroviral therapy | COHORT | OUTCOMES | Anti-HIV Agents - pharmacology | Humans | Middle Aged | Male | HIV - drug effects | Viral Load | Adenine - therapeutic use | Lamivudine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Health Resources | Lesotho | Adenine - analogs & derivatives | Cross-Sectional Studies | Organophosphonates - therapeutic use | HIV Infections - virology | Zidovudine - pharmacology | Logistic Models | Adenine - pharmacology | Benzoxazines - therapeutic use | Antiretroviral Therapy, Highly Active | Organophosphonates - pharmacology | HIV Infections - drug therapy | Zidovudine - therapeutic use | DNA polymerases | Analysis | Comparative studies | Antiretroviral drugs | Pharmacology | Drug therapy | Index Medicus
Journal Article